e3banpc-742.jpg e3banph-408.jpg

MEDIA RELEASE

2024
2023
  • Jan 02, 2024

    YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024

    YolTech invites partners, investors, and stakeholders to join the session

    Read More

  • Dec 17, 2023

    First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

    The study by YolTech is a single-arm, open-label, dose-escalation clinical trial

    Read More

XML 地图 | Sitemap 地图